Jaundice natural history, complications, and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and  recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.  
Natural history of jaundice varies greatly and symptoms can manifest at any age of life depending on the underlying cause. The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and  recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.  


==Natural History==
==Natural History==
* The symptoms of jaundice may develop as early as neonatal period<ref name="pmid20497361">{{cite journal| author=Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A| title=Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn. | journal=Pediatr Int | year= 2010 | volume= 52 | issue= 5 | pages= 769-72 | pmid=20497361 | doi=10.1111/j.1442-200X.2010.03170.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20497361  }}</ref> to any decade of life depending on the underlying cause, and start with symptoms such as yellowish discoloration of eyes and sclera. Typically, jaundice is not detectable clinically until serum bilirubin reaches 2.5 mg/dL.2 It is first seen in the conjunctiva or oral mucous membranes such as the hard palate or under the tongue. As the serum concentration of bilirubin rises, jaundice proceeds caudally.  
Natural history of jaundice is as follows:
* Jaundice appearing over a few days to a week implies hepatitis, whether drug or toxin induced, viral<ref name="pmid4191502">{{cite journal| author=Krugman S, Giles JP| title=Viral hepatitis. New light on an old disease. | journal=JAMA | year= 1970 | volume= 212 | issue= 6 | pages= 1019-29 | pmid=4191502 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4191502  }}</ref> or bacterial (i.e., leptospirosis). Jaundice appearing over the course of weeks implies a subacute hepatitis or extrahepatic obstruction due to malignancy<ref name="pmid21460876">{{cite journal| author=Patel T| title=Cholangiocarcinoma--controversies and challenges. | journal=Nat Rev Gastroenterol Hepatol | year= 2011 | volume= 8 | issue= 4 | pages= 189-200 | pmid=21460876 | doi=10.1038/nrgastro.2011.20 | pmc=3888819 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21460876 }}</ref>, gallstone, chronic pancreatitis, or stricture in the common bile duct. Jaundice of fluctuating intensity implicates gallstones, ampullary<ref name="pmid15960930">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930 }}</ref> carcinoma, or possible drug hepatitis.
*The symptoms of [[jaundice]] may develop as early as [[neonatal]] period to any decade of life depending on the underlying cause, and originates with symptoms such as [[Yellowish discoloration|yellowish discoloration of eyes]] and [[sclera]].<ref name="pmid204973612">{{cite journal| author=Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A| title=Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn. | journal=Pediatr Int | year= 2010 | volume= 52 | issue= 5 | pages= 769-72 | pmid=20497361 | doi=10.1111/j.1442-200X.2010.03170.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20497361  }}</ref> Typically, jaundice is not evident clinically until serum bilirubin level reaches 2.5 mg/dL. It is first seen in the conjunctiva or oral mucous membranes such as the hard palate or under the tongue. As the serum concentration of bilirubin rises, jaundice proceeds caudally.
* If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Jaundice appearing over a few days to couple of  week implies an acute course (hepatitis, whether drug or toxin induced, viral or bacterial i.e., leptospirosis). <ref name="pmid41915022">{{cite journal| author=Krugman S, Giles JP| title=Viral hepatitis. New light on an old disease. | journal=JAMA | year= 1970 | volume= 212 | issue= 6 | pages= 1019-29 | pmid=4191502 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4191502  }}</ref> Jaundice appearing over the course of few weeks points towards a subacute hepatitis or extrahepatic obstruction (malignancy, gallstone, chronic pancreatitis, or stricture in the common bile duct). Jaundice of fluctuating intensity implicates gallstones, ampullary carcinoma, or possible drug hepatitis.<ref name="pmid159609302">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930 }}</ref><ref name="pmid214608762">{{cite journal| author=Patel T| title=Cholangiocarcinoma--controversies and challenges. | journal=Nat Rev Gastroenterol Hepatol | year= 2011 | volume= 8 | issue= 4 | pages= 189-200 | pmid=21460876 | doi=10.1038/nrgastro.2011.20 | pmc=3888819 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21460876 }}</ref>
 
*2/100,000 patients in USA with jaundice may progress to develop acute liver failure which is manifested as sudden onset of encephlopathy and liver cell dysfunction leading to coagulopathy in a healthy person with no known underlying liver disease previously. <ref name="Ostapowicz2002">{{cite journal|last1=Ostapowicz|first1=George|title=Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States|journal=Annals of Internal Medicine|volume=137|issue=12|year=2002|pages=947|issn=0003-4819|doi=10.7326/0003-4819-137-12-200212170-00007}}</ref>
 
==Complications==
==Complications==
Common complications of jaundice include:<ref name="pmid28272079">{{cite journal| author=Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV et al.| title=Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis. | journal=J Clin Gastroenterol | year= 2017 | volume= 51 | issue= 6 | pages= 548-556 | pmid=28272079 | doi=10.1097/MCG.0000000000000805 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28272079  }}</ref>
Common complications of jaundice include:<ref name="pmid28272079">{{cite journal| author=Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV et al.| title=Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis. | journal=J Clin Gastroenterol | year= 2017 | volume= 51 | issue= 6 | pages= 548-556 | pmid=28272079 | doi=10.1097/MCG.0000000000000805 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28272079  }}</ref>

Revision as of 17:59, 7 February 2018

Jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Jaundice natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Jaundice natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Jaundice natural history, complications, and prognosis

CDC on Jaundice natural history, complications, and prognosis

Jaundice natural history, complications, and prognosis in the news

Blogs on Jaundice natural history, complications, and prognosis

Directions to Hospitals Treating Jaundice

Risk calculators and risk factors for Jaundice natural history, complications, and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Natural history of jaundice varies greatly and symptoms can manifest at any age of life depending on the underlying cause. The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.

Natural History

Natural history of jaundice is as follows:

  • The symptoms of jaundice may develop as early as neonatal period to any decade of life depending on the underlying cause, and originates with symptoms such as yellowish discoloration of eyes and sclera.[1] Typically, jaundice is not evident clinically until serum bilirubin level reaches 2.5 mg/dL. It is first seen in the conjunctiva or oral mucous membranes such as the hard palate or under the tongue. As the serum concentration of bilirubin rises, jaundice proceeds caudally.
  • Jaundice appearing over a few days to couple of week implies an acute course (hepatitis, whether drug or toxin induced, viral or bacterial i.e., leptospirosis). [2] Jaundice appearing over the course of few weeks points towards a subacute hepatitis or extrahepatic obstruction (malignancy, gallstone, chronic pancreatitis, or stricture in the common bile duct). Jaundice of fluctuating intensity implicates gallstones, ampullary carcinoma, or possible drug hepatitis.[3][4]
  • 2/100,000 patients in USA with jaundice may progress to develop acute liver failure which is manifested as sudden onset of encephlopathy and liver cell dysfunction leading to coagulopathy in a healthy person with no known underlying liver disease previously. [5]

Complications

Common complications of jaundice include:[6]

Prognosis

  • The prognosis for individuals with jaundice varies with the underlying cause of the condition. There are certain conditions that has the most favorable prognosis leading to full recovery. However, more serious causes of jaundice like acute suppurative cholangitis or fulminant hepatic failure can sometimes be fatal despite medical or surgical intervention. The mortality can be as high as 80% .[7]
  • The development and severity of complications as well as patient's underlying health and comorbidities have a huge impact on the prognosis of patients.

References

  1. Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A (2010). "Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn". Pediatr Int. 52 (5): 769–72. doi:10.1111/j.1442-200X.2010.03170.x. PMID 20497361.
  2. Krugman S, Giles JP (1970). "Viral hepatitis. New light on an old disease". JAMA. 212 (6): 1019–29. PMID 4191502.
  3. Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A; et al. (2005). "Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage". Clin Transl Oncol. 7 (5): 189–97. PMID 15960930.
  4. Patel T (2011). "Cholangiocarcinoma--controversies and challenges". Nat Rev Gastroenterol Hepatol. 8 (4): 189–200. doi:10.1038/nrgastro.2011.20. PMC 3888819. PMID 21460876.
  5. Ostapowicz, George (2002). "Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States". Annals of Internal Medicine. 137 (12): 947. doi:10.7326/0003-4819-137-12-200212170-00007. ISSN 0003-4819.
  6. Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV; et al. (2017). "Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis". J Clin Gastroenterol. 51 (6): 548–556. doi:10.1097/MCG.0000000000000805. PMID 28272079.
  7. Lee WM (1993). "Acute liver failure". N Engl J Med. 329 (25): 1862–72. doi:10.1056/NEJM199312163292508. PMID 8305063.


Template:WH Template:WS